UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells Journal article
He, Tianzhen, Liu, Shuoyang, Chen, Shaokui, Ye, Jingyi, Wu, Xueqiang, Bian, Zhaoxiang, Chen, Xin. The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9.
Authors:  He, Tianzhen;  Liu, Shuoyang;  Chen, Shaokui;  Ye, Jingyi;  Wu, Xueqiang; et al.
Favorite | TC[WOS]:34 TC[Scopus]:34  IF:5.7/6.8 | Submit date:2018/10/30
Tumor Necrosis Factor  Tnf Receptor Type Ii  P38 Mapk  Cd4(+)Foxp3(+) Regulatory t Cells  Proliferation  
Dietary therapy may be sufficient for type 1 diabetes treatment Journal article
Liu, Shuoyang, Chen, Xin. Dietary therapy may be sufficient for type 1 diabetes treatment[J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15(2), 85-87.
Authors:  Liu, Shuoyang;  Chen, Xin
Favorite | TC[WOS]:7 TC[Scopus]:2  IF:21.8/19.9 | Submit date:2018/10/30
Dietary therapy may be sufficient for type 1 diabetes treatment Journal article
Liu,Shuoyang, Chen,Xin. Dietary therapy may be sufficient for type 1 diabetes treatment[J]. Cellular and Molecular Immunology, 2018, 15(2), 85-87.
Authors:  Liu,Shuoyang;  Chen,Xin
Favorite | TC[WOS]:7 TC[Scopus]:2  IF:21.8/19.9 | Submit date:2021/03/01